Literature DB >> 23195672

Renal impairment is associated with coronary heart disease in HIV-positive men.

Lucy J Campbell1, Mitesh Desai, Aseel Hegazi, Fowzia Ibrahim, Narbeh Melikian, Phillip Hay, Julie M Fox, Frank A Post.   

Abstract

BACKGROUND: Chronic kidney disease is a risk factor for coronary heart disease (CHD). The association between renal impairment and CHD in HIV-positive patients remains poorly described.
OBJECTIVE: To describe the CHD incidence in a cohort of HIV-positive patients and to examine the relationship between reduced estimated glomerular filtration rate (eGFR) and incident CHD.
METHODS: We studied 7,828 HIV-positive patients who were followed up at 3 South London clinics between January 2004 and December 2009. CHD events were identified from electronic records and through elevated troponin levels. Multivariate Poisson regression analysis was used to identify factors associated with CHD among HIV-positive men.
RESULTS: The incidence of CHD among men was 1.2 (95% CI, 0.8-1.8) per 1,000 person-years of follow-up, with 28 patients (0.4%) having experienced 32 CHD events. In adjusted analyses, older age (incidence rate ratios [IRR], 2.81; 95% CI, 1.51-5.25) and hepatitis C virus (HCV) status (IRR, 3.94; 95% CI, 1.00-15.5) were significantly associated with CHD. Although eGFR as a continuous variable was not associated with CHD, an eGFR <75 mL/min remained associated with incident CHD (IRR, 4.30; 95% CI, 1.33-14.5) after adjustment for age. No association between CHD and abacavir exposure was observed (IRR, 0.94; 95% CI, 0.30-2.99).
CONCLUSIONS: The incidence of CHD in this ethnically diverse cohort was low. Our data suggest that impaired renal function identifies patients at increased risk of CHD events in whom management of traditional CHD risk factors should be prioritized.

Entities:  

Mesh:

Year:  2012        PMID: 23195672     DOI: 10.1310/hct1306-343

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  5 in total

1.  Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

Authors:  Lene Ryom; Jens D Lundgren; Mike Ross; Ole Kirk; Matthew Law; Philippe Morlat; Eric Fontas; Colette Smit; Christoph A Fux; Camilla I Hatleberg; Stéphane de Wit; Caroline A Sabin; Amanda Mocroft
Journal:  J Infect Dis       Date:  2016-08-02       Impact factor: 5.226

Review 2.  Cardiovascular disease and HIV infection.

Authors:  Virginia A Triant
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

3.  A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.

Authors:  Rebeccah A McKibben; Sabina A Haberlen; Wendy S Post; Todd T Brown; Matthew Budoff; Mallory D Witt; Lawrence A Kingsley; Frank J Palella; Chloe L Thio; Eric C Seaberg
Journal:  J Infect Dis       Date:  2015-07-27       Impact factor: 5.226

4.  Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals-a clinical cohort study.

Authors:  Teri-Louise Davies; Mark Gompels; Sarah Johnston; Begoña Bovill; Margaret T May
Journal:  BMJ Open       Date:  2013-10-25       Impact factor: 2.692

5.  Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study.

Authors:  Kuan Ken Lee; Dominik Stelzle; Rong Bing; Mohamed Anwar; Fiona Strachan; Sophia Bashir; David E Newby; Jasmit S Shah; Michael H Chung; Gerald S Bloomfield; Chris T Longenecker; Shashwatee Bagchi; Shyamasundaran Kottilil; Sarah Blach; Homie Razavi; Peter R Mills; Nicholas L Mills; David A McAllister; Anoop S V Shah
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.